<?xml version="1.0"?>
<Articles JournalTitle="Journal of Family and Reproductive Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Family and Reproductive Health</JournalTitle>
      <Issn>1735-8949</Issn>
      <Volume>4</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Development of New Therapeutic Strategies in Gynecological Cancers in Iran by Utilizing Xenograft Model of Ovarian Adenocarcinoma</title>
    <FirstPage>105</FirstPage>
    <LastPage>107</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Zohreh</FirstName>
        <LastName>Mazaheri</LastName>
        <affiliation locale="en_US">Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Samad</FirstName>
        <LastName>Muhammadnejad</LastName>
        <affiliation locale="en_US">Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ahad</FirstName>
        <LastName>Muhammadnejad</LastName>
        <affiliation locale="en_US">Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Moein</FirstName>
        <LastName>Zargarzadeh</LastName>
        <affiliation locale="en_US">Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Haghighi</LastName>
        <affiliation locale="en_US">Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Ali Oghabian</LastName>
        <affiliation locale="en_US">Research Center for Science and Technology in Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farrokh</FirstName>
        <LastName>Tirgari</LastName>
        <affiliation locale="en_US">Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Saeid</FirstName>
        <LastName>Amanpour</LastName>
        <affiliation locale="en_US">Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>04</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: To evaluate the potentiality of OVCAR&#x2013;3 cell line of ovarian adenocarcinoma as a xenograft model for ovarian adenocarcinoma in nude mice.
Materials and methods: The cell line isolated from advanced human ovarian adenocarcinoma, were inoculated to eight nude mice and two months later. Established tumors were transferred to pathology laboratory to be prepared by H&amp;E staining and immunohistochemical staining with CA125 antibody.
Results: Study of H&amp;E slides showed advanced adenocarcinoma. The CA125 Tumor marker was also positive in tumoral tissue.
Conclusion: Established tumors showed excellently the characteristics of ovarian adenocarcinoma. This model can be used to evaluate new treatment strategies.</abstract>
    <web_url>https://jfrh.tums.ac.ir/index.php/jfrh/article/view/99</web_url>
    <pdf_url>https://jfrh.tums.ac.ir/index.php/jfrh/article/download/99/99</pdf_url>
  </Article>
</Articles>
